ORBIMED ADVISORS LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$9.9T
Holdings
157
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (157 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | GILDGILEAD SCIENCES INC | 287,600 | $19.8B | 0.20% | |
| 102 | 290ACHINOOK THERAPEUTICS INC | 1,333,801 | $18.8B | 0.19% | |
| 103 | CTIC1USDCTI BIOPHARMA CORP | 7,520,600 | $18.8B | 0.19% | |
| 104 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $16.7B | 0.17% | |
| 105 | GLPGGALAPAGOS NV | 230,905 | $15.9B | 0.16% | |
| 106 | NAUTNAUTILUS BIOTECHNOLOGY INC | 1,546,700 | $15.6B | 0.16% | |
| 107 | VORVOR BIOPHARMA INC | 833,333 | $15.5B | 0.16% | |
| 108 | 698ACHILLES THERAPEUTICS PLC | 1,584,845 | $15.5B | 0.16% | |
| 109 | JNCEEURJOUNCE THERAPEUTICS INC | 2,147,400 | $14.6B | 0.15% | |
| 110 | QUREUNIQURE NV | 471,174 | $14.5B | 0.15% | |
| 111 | —SYNLOGIC INC | 3,696,662 | $14.4B | 0.15% | |
| 112 | MISTMILESTONE PHARMACEUTICALS IN | 2,583,821 | $14.2B | 0.14% | |
| 113 | AMGNAMGEN INC | 57,100 | $13.9B | 0.14% | |
| 114 | RLAYRELAY THERAPEUTICS INC | 350,000 | $12.8B | 0.13% | |
| 115 | ALECALECTOR INC | 611,478 | $12.7B | 0.13% | |
| 116 | PHGEBIOMX INC | 2,313,489 | $12.6B | 0.13% | |
| 117 | MAPSWM TECHNOLOGY INC | 700,400 | $12.5B | 0.13% | |
| 118 | CVACCUREVAC N V | 170,000 | $12.5B | 0.13% | Put |
| 119 | BLUBELLUS HEALTH INC NEW | 3,954,800 | $12.3B | 0.12% | |
| 120 | AVTEAEROVATE THERAPEUTICS INC | 535,714 | $12.2B | 0.12% | |
| 121 | —ONCOCYTE CORP | 2,100,000 | $12.1B | 0.12% | |
| 122 | IPSCCENTURY THERAPEUTICS INC | 407,047 | $11.9B | 0.12% | |
| 123 | —CONVEY HLDG PARENT INC | 1,000,000 | $11.4B | 0.12% | |
| 124 | CVRXCVRX INC | 400,000 | $11.2B | 0.11% | |
| 125 | —SYROS PHARMACEUTICALS INC | 1,837,500 | $10.0B | 0.10% | |
| 126 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 6,000,000 | $9.7B | 0.10% | |
| 127 | CTMXCYTOMX THERAPEUTICS INC | 1,513,168 | $9.6B | 0.10% | |
| 128 | —9 METERS BIOPHARMA INC | 8,565,974 | $9.4B | 0.10% | |
| 129 | NBPI MAB | 111,120 | $9.3B | 0.09% | |
| 130 | GYRECATALYST BIOSCIENCES INC | 2,118,600 | $9.2B | 0.09% | |
| 131 | ASNSUSDX4 PHARMACEUTICALS INC | 1,373,849 | $8.9B | 0.09% | |
| 132 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $8.8B | 0.09% | |
| 133 | —ASLAN PHARMACEUTICALS LTD | 2,520,000 | $8.3B | 0.08% | |
| 134 | ALXOALX ONCOLOGY HLDGS INC | 150,000 | $8.2B | 0.08% | |
| 135 | STROSUTRO BIOPHARMA INC | 433,700 | $8.1B | 0.08% | |
| 136 | NRIXNURIX THERAPEUTICS INC | 300,000 | $8.0B | 0.08% | |
| 137 | GLUEMONTE ROSA THERAPEUTICS INC | 350,000 | $7.9B | 0.08% | |
| 138 | —LANDOS BIOPHARMA INC | 681,000 | $7.9B | 0.08% | |
| 139 | DYNDYNE THERAPEUTICS INC | 350,000 | $7.4B | 0.07% | |
| 140 | OTICEUROTONOMY INC | 3,250,000 | $7.2B | 0.07% | |
| 141 | NBTXNANOBIOTIX SA | 500,000 | $6.9B | 0.07% | |
| 142 | ACRSACLARIS THERAPEUTICS INC | 362,000 | $6.4B | 0.06% | |
| 143 | —PROMETHEUS BIOSCIENCES INC | 250,000 | $6.1B | 0.06% | |
| 144 | VERVVERVE THERAPEUTICS INC | 100,000 | $6.0B | 0.06% | |
| 145 | LUNGPULMONX CORP | 125,000 | $5.5B | 0.06% | |
| 146 | —STRONGBRIDGE BIOPHARMA PLC | 1,744,669 | $5.2B | 0.05% | |
| 147 | —HEALTH SCIENCES ACQ CORP 2 | 500,000 | $5.1B | 0.05% | |
| 148 | OGNORGANON & CO | 166,939 | $5.1B | 0.05% | |
| 149 | SRPTSAREPTA THERAPEUTICS INC | 64,700 | $5.0B | 0.05% | |
| 150 | TARAPROTARA THERAPEUTICS INC | 450,000 | $4.4B | 0.04% | |
| 151 | ADAGADAGENE INC | 275,000 | $3.7B | 0.04% | |
| 152 | —TALARIS THERAPEUTICS INC | 247,240 | $3.6B | 0.04% | |
| 153 | INZYINOZYME PHARMA INC | 188,704 | $3.2B | 0.03% | |
| 154 | IFRXINFLARX NV | 1,064,118 | $3.2B | 0.03% | |
| 155 | KZRKEZAR LIFE SCIENCES INC | 557,191 | $3.0B | 0.03% | |
| 156 | —LONGBOARD PHARMACEUTICALS IN | 113,500 | $1.0B | 0.01% | |
| 157 | MAPSWWM TECHNOLOGY INC | 150,200 | $954.0M | 0.01% | Call |
| 158 | PPBTPURPLE BIOTECH LTD | 17,712 | $86.0M | 0.00% |
PreviousPage 2 of 2